Breathing Circuit Market Size & Industry Outlook
The global breathing circuit market size reached US$ 1.55 Billion in 2023 with a rise of US$ 1.64 Billion in 2024 and is expected to reach US$ 2.75 Billion by 2033, growing at a CAGR of 5.9% during the forecast period 2025-2033.
Technology developments and an increase in surgical procedures are driving the breathing circuit market's quick growth. Annually, the number of surgeries performed worldwide is rising. Delivering anesthetic safely and effectively is necessary for more procedures. Accurate regulation of oxygen and anesthetic gases is guaranteed via breathing circuits. Advanced, dependable, and user-friendly technology are essential for hospitals. Circuit design and materials are improved by technological advancements.
Circuits of this day improve temperature and humidity regulation and eliminate dead space. They make patients more comfortable and reduce the danger of infection. Respiratory parameters are continuously monitored by smart monitoring equipment. The use of eco-friendly and disposable circuits is growing. Solutions that are sustainable and economical are preferred by healthcare professionals. Acceptance is fueled by an increasing emphasis on surgical effectiveness and patient safety.
Key Highlights
- North America is dominating the global breathing circuit market with the largest revenue share of a 48.5% in 2024
- The Asia Pacific region is the fastest-growing region in the global breathing circuit market, with a CAGR of 7.7% in 2024
- The semi-closed breathing circuits from product type are dominating the breathing circuit market with a 42.3% share in 2024
- The anesthesia segment from application is dominating the breathing circuit market with a 55.3% share in 2024
- Top companies in the breathing circuit market are Medtronic plc, Ambu A/S, Flexicare Medical Ltd, Fisher & Paykel Healthcare Limited, Drägerwerk AG & Co. KGaA, Hamilton Medical, Medical EXPO, Meditera, GE HealthCare, and gpcmedical, among others.
Market Dynamics
Drivers: Rising prevalence of respiratory diseases are accelerating the growth of the breathing circuit market
The market for breathing circuits is significantly influenced by the growing incidence of respiratory illnesses. The prevalence of chronic illnesses like sleep apnea, asthma, and COPD is rising globally. The demand for ventilation and respiratory support rises with these conditions. Modern breathing circuits are necessary for efficient patient treatment in clinics and hospitals. For the safe delivery of gases, anesthesiology treatments also rely on dependable circuits.
Owing to factors like prevalence, according to the World Health Organization (WHO), over 80 million people are affected with respiratory diseases, and many more are undiagnosed worldwide.
Moreover, even though 81.7 million people in the region are living with a chronic respiratory disease (CRD) and 6.8 million are newly diagnosed each year, CRDs have slipped from policy priorities, leaving millions without the care and attention they need. COPD and asthma account for the majority of CRD cases in the region. Future projections indicate that COPD cases will rise globally by 23% between 2020 and 2050.
Restraints: High costs of advanced devices limit adoption and are hampering the growth of the breathing circuit market
Adoption of improved breathing circuits is being hindered by their high cost. Budgetary restrictions plague many hospitals, particularly in developing nations. Manufacturing costs are raised by sophisticated features like integrated monitoring, heated humidifiers, and antimicrobial coatings. Procurement becomes costly when these expenses are transferred to healthcare providers. These high-end gadgets are sometimes out of reach for smaller clinics and home care settings. Market expansion is slowed by limited acceptance.
Furthermore, expensive prices may deter regular upgrades or replacements, which would lower sales volume. Costs are also increased by regulatory compliance and quality certifications.
For more details on this report, see Request for Sample
Breathing Circuit Market, Segmentation Analysis
The global breathing circuit market is segmented based on product type, application, end user and region
By Product Type: The semi-closed breathing circuits from product type are dominating the breathing circuit market with a 42.3% share in 2024
The market for breathing circuits worldwide is dominated by the semi-closed breathing circuits segment. These circuits effectively eliminate carbon dioxide and recycle exhaled gases. They cut hospital expenses by reducing the need of anesthetic drugs. Better control over gas concentrations and steady oxygen delivery are offered by semi-closed circuits. By reducing the possibility of hypoxia or hypercapnia, they enhance patient safety. The circuits are adaptable and appropriate for patients of all ages. Adoption is further accelerated by technological innovations like low-resistance valves and heated humidifiers.
Additionally, this area is dominant due to advancement and upgradation in devices and new product launches. For instance, In August 2023, ResMed revealed new semi-closed breathing circuit designs that emphasize better patient-ventilator synchronization and less dead space in its ventilation accessories.
By Application: The anesthesia segment form application is dominating the breathing circuit market with a 55.3% share in 2024
The market for breathing circuits is dominated by the anesthetic segment. Every year, hospitals conduct millions of surgeries. Accurate gas supply is necessary for anesthesia. Both closed and semi-closed circuits are frequently utilized. They supply anesthetic gases and regulated oxygen. During surgery, patient safety is crucial. Breathing circuits lessen exposure to the environment and gas waste. Temperature and humidity control are enhanced via sophisticated circuitry. They also reduce the chance of infection. The need for anesthesia equipment is increased by an increase in surgical procedures.
Additionally, manufacturers' ongoing advancements and new product introductions are enhancing accuracy and portability. For instance, in February 2023, VERO Biotech Inc. received FDA approval for its second-generation GENOSYL Inhaled Nitric Oxide (iNO) delivery system. It became the first device approved for both rebreathing and non-rebreathing anesthesia, enhancing patient care, reducing hospital costs, and minimizing environmental pollution from waste anesthetic gases.
Breathing Circuit Market, Geographical Analysis
North America is dominating the global breathing circuit market with a 48.5% in 2024
The market for breathing circuits is dominated as a result of North America's advanced healthcare system, the use of cutting-edge technology, and an increase in surgical and respiratory cases. Supportive reimbursement policies, frequent product releases, highly skilled healthcare professionals, and stringent regulatory standards all contributed to the region's supremacy in the global breathing circuit market.
The market for breathing circuits is expanding in the USA because to factors such sophisticated healthcare infrastructure, regular product launches, cutting-edge respiratory technologies, positive FDA approvals, and 510k clearance for circuits that improve surgical and critical care efficiency. For instance, in June 2024, Medline Industries, LP received FDA 510(k) clearance for its Hudson RCI Dri-Tech Breathing Circuits, including multiple adult circuit kits and ventilator accessories. These advanced circuits were designed to improve respiratory care efficiency, ensuring reliable performance, safety, and compatibility across various clinical and anesthesia applications.
Europe is the second region after North America which is expected to dominate the global breathing circuit market with a 34.5% in 2024
The market for breathing circuits in Europe is growing as a result of improvements in healthcare infrastructure, an older population, and an increase in respiratory and surgical cases. Across hospitals and clinical settings, frequent product introductions, advantageous reimbursement schemes, and ongoing EU and CE mark approvals are stimulating innovation, improving patient safety, and speeding up regional market expansion.
Owing to factors like continuous EU and CE mark approvals, for instance, in December 2024, Beyond Air’s LungFit PH system received CE mark approval, allowing its marketing within the European Union and other regions and officially certifying the device’s breathing circuit component for compliance with EU regulatory standards.
The Asia Pacific region is the fastest-growing region in the global breathing circuit market, with a CAGR of 7.7% in 2024
The market for breathing circuits in the Asia-Pacific region, which includes China, India, South Korea, and Japan, is growing rapidly as a result of rising healthcare costs, technological advancements, an increase in respiratory and surgical cases, improved hospital infrastructure, and a growing awareness of the importance of prompt critical care interventions.
Moreover, partnerships and collaboration of companies with other distributors fuel the market. For instance, in 2023, Weigao Group announced a strategic partnership to expand its distribution network in the Asia-Pacific region. While specific details about the partners were not disclosed, this move indicates Weigao's intent to strengthen its presence in the respiratory device market.
Competitive Landscape
Top companies in the breathing circuit market are Medtronic, Ambu A/S, Flexicare Medical Ltd, Fisher & Paykel Healthcare Limited, Drägerwerk AG & Co. KGaA, Hamilton Medical, Medical EXPO, Meditera, GE HealthCare, and gpcmedical, among others.
Medtronic: Medtronic is a global leader in medical technology, offering comprehensive solutions in the breathing circuit market. Under its DAR brand, Medtronic provides a full range of filters, breathing circuits, and other respiratory care accessories designed to meet the needs of medical staff and patients in the operating room. The company's offerings are integral to advanced airway management, ensuring patient safety and supporting clinical efficiency in various healthcare settings.
Key Developments:
- In June 2024, Medline Industries received FDA 510(k) clearance for its Hudson RCI Dri-Tech Breathing Circuits, including adult circuits, single-limb kits, filter kits, and ventilator accessories, supporting safe and effective respiratory care in clinical settings.
- In October 2023, AirLife, formerly SunMed, completed the acquisition of Avanos Medical’s respiratory health business, including the BALLARD, MICROCUFF, and endOclear product lines. This acquisition expanded AirLife’s portfolio of anesthesia and respiratory care solutions, enhancing its ability to deliver advanced breathing products that supported optimal patient outcomes.
Market Scope
| Metrics | Details | |
| CAGR | 5.9% | |
| Market Size Available for Years | 2022-2033 | |
| Estimation Forecast Period | 2025-2033 | |
| Revenue Units | Value (US$ Bn) | |
| Segments Covered | By Product Type | Semi-closed breathing systems, Semi Open Breathing Circuits, Open Breathing Circuits, Closed Breathing Circuits |
| By Application | Anesthesia, Respiratory Dysfunction and Others | |
| By End User | Hospitals, Clinics, Ambulatory Surgical Centers and Others | |
| Regions Covered | North America, Europe, Asia-Pacific, South America and the Middle East & Africa | |
The global breathing circuit market report delivers a detailed analysis with 62 key tables, more than 52 visually impactful figures, and 159 pages of expert insights, providing a complete view of the market landscape.
Suggestions for Related Report
For more medical device-related reports, please click here
